SG Americas Securities LLC Has $3.59 Million Stock Holdings in Kenvue Inc. (NYSE:KVUE)

SG Americas Securities LLC trimmed its stake in Kenvue Inc. (NYSE:KVUE - Free Report) by 45.8% in the first quarter, according to the company in its most recent disclosure with the SEC. The firm owned 149,704 shares of the company's stock after selling 126,346 shares during the quarter. SG Americas Securities LLC's holdings in Kenvue were worth $3,590,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds have also recently bought and sold shares of the stock. Handelsbanken Fonder AB lifted its stake in shares of Kenvue by 2.9% during the fourth quarter. Handelsbanken Fonder AB now owns 742,184 shares of the company's stock worth $15,846,000 after purchasing an additional 21,222 shares in the last quarter. Alberta Investment Management Corp raised its holdings in shares of Kenvue by 23.2% during the 4th quarter. Alberta Investment Management Corp now owns 582,895 shares of the company's stock valued at $12,445,000 after buying an additional 109,700 shares during the period. Longbow Finance SA lifted its position in Kenvue by 5.0% during the 4th quarter. Longbow Finance SA now owns 280,568 shares of the company's stock worth $5,990,000 after acquiring an additional 13,287 shares in the last quarter. Steward Partners Investment Advisory LLC boosted its holdings in Kenvue by 143.1% in the 4th quarter. Steward Partners Investment Advisory LLC now owns 47,938 shares of the company's stock worth $1,023,000 after acquiring an additional 28,216 shares during the period. Finally, CORDA Investment Management LLC. grew its position in Kenvue by 1.4% in the fourth quarter. CORDA Investment Management LLC. now owns 1,253,096 shares of the company's stock valued at $26,754,000 after acquiring an additional 17,466 shares in the last quarter. Institutional investors and hedge funds own 97.64% of the company's stock.

Analyst Ratings Changes

A number of research analysts have recently commented on KVUE shares. Piper Sandler boosted their target price on shares of Kenvue from $24.00 to $27.00 and gave the stock an "overweight" rating in a research report on Monday, February 24th. Barclays boosted their price objective on shares of Kenvue from $22.00 to $23.00 and gave the stock an "equal weight" rating in a report on Monday, May 12th. Evercore ISI initiated coverage on Kenvue in a research note on Monday, March 24th. They set an "in-line" rating and a $25.00 target price for the company. Canaccord Genuity Group lifted their target price on Kenvue from $24.00 to $29.00 and gave the stock a "buy" rating in a research report on Wednesday, March 5th. Finally, Citigroup reissued a "neutral" rating on shares of Kenvue in a report on Friday. Seven analysts have rated the stock with a hold rating and five have given a buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of "Hold" and a consensus target price of $25.33.

Kenvue Stock Performance

Shares of KVUE traded down $0.21 during mid-day trading on Tuesday, hitting $21.45. The stock had a trading volume of 17,940,293 shares, compared to its average volume of 16,480,465. Kenvue Inc. has a fifty-two week low of $17.67 and a fifty-two week high of $25.17. The company has a quick ratio of 0.60, a current ratio of 0.86 and a debt-to-equity ratio of 0.63. The company has a market cap of $41.15 billion, a PE ratio of 38.99, a PEG ratio of 3.36 and a beta of 0.98. The company's fifty day simple moving average is $23.03 and its two-hundred day simple moving average is $22.46.

Kenvue (NYSE:KVUE - Get Free Report) last released its earnings results on Thursday, May 8th. The company reported $0.24 earnings per share for the quarter, beating the consensus estimate of $0.23 by $0.01. Kenvue had a net margin of 6.90% and a return on equity of 20.87%. The firm had revenue of $3.74 billion during the quarter, compared to analyst estimates of $3.69 billion. During the same quarter in the previous year, the firm earned $0.28 earnings per share. The firm's revenue for the quarter was down 3.9% compared to the same quarter last year. On average, equities analysts expect that Kenvue Inc. will post 1.14 earnings per share for the current year.

Kenvue Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, May 28th. Shareholders of record on Wednesday, May 14th were given a dividend of $0.205 per share. The ex-dividend date was Wednesday, May 14th. This represents a $0.82 dividend on an annualized basis and a yield of 3.82%. Kenvue's dividend payout ratio (DPR) is presently 149.09%.

Kenvue Company Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.